These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32542142)

  • 1. Can Magnetic Resonance Imaging Replace Mammography and Ultrasonography for the Detection of Breast Lesions?
    Yilmaz Y; Sezgin Bener G; Atahan K; Acar N; Acar T; Kar H; Tosun F; Gokova M
    Cureus; 2020 May; 12(5):e8087. PubMed ID: 32542142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging of the breast as a problem-solving method: to be or not to be?
    Oztekin PS; Kosar PN
    Breast J; 2014; 20(6):622-31. PubMed ID: 25200378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interobserver Variability Between Breast Imagers Using the Fifth Edition of the BI-RADS MRI Lexicon.
    Grimm LJ; Anderson AL; Baker JA; Johnson KS; Walsh R; Yoon SC; Ghate SV
    AJR Am J Roentgenol; 2015 May; 204(5):1120-4. PubMed ID: 25905951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of Malignancy and Imaging Characteristics of Probably Benign Lesions Seen at Breast MRI.
    Grimm LJ; Anderson AL; Baker JA; Johnson KS; Walsh R; Yoon SC; Ghate SV
    AJR Am J Roentgenol; 2015 Aug; 205(2):442-7. PubMed ID: 26204298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Value of Lesion Size as an Adjunct to the BI-RADS-MRI 2013 Descriptors in the Diagnosis of Solitary Breast Masses.
    Kawai M; Kataoka M; Kanao S; Iima M; Onishi N; Ohashi A; Sakaguchi R; Toi M; Togashi K
    Magn Reson Med Sci; 2018 Jul; 17(3):203-210. PubMed ID: 29213007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
    Uematsu T; Yuen S; Kasami M; Uchida Y
    Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Value of Hook Wire Localization Technique for Non-Palpable Breast Lesions.
    Demiral G; Senol M; Bayraktar B; Ozturk H; Celik Y; Boluk S
    J Clin Med Res; 2016 May; 8(5):389-95. PubMed ID: 27081425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management for BI-RADS category 3 lesions detected in preoperative breast MR imaging of breast cancer patients.
    Gweon HM; Cho N; Kim SY; Koo HR; Seo M; Chu A; Son EJ
    Eur Radiol; 2017 Aug; 27(8):3211-3216. PubMed ID: 28083693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Diagnostic Accuracies of USG, MG and MRI Modalities Defined with BI-RADS Classification System.
    Serinsöz S; Akturk R
    Curr Med Imaging; 2022; 18(9):986-995. PubMed ID: 35319382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonmasslike enhancement at breast MR imaging: the added value of mammography and US for lesion categorization.
    Thomassin-Naggara I; Trop I; Chopier J; David J; Lalonde L; Darai E; Rouzier R; Uzan S
    Radiology; 2011 Oct; 261(1):69-79. PubMed ID: 21771958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of breast MRI for BI-RADS category 4B mammographic microcalcification: based on the 5
    Eun NL; Son EJ; Gweon HM; Youk JH; Kim JA
    Clin Radiol; 2018 Aug; 73(8):750-755. PubMed ID: 29853301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
    Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
    Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of BI-RADS Assessment Category 4 Subdivisions for Screening Breast MRI.
    Strigel RM; Burnside ES; Elezaby M; Fowler AM; Kelcz F; Salkowski LR; DeMartini WB
    AJR Am J Roentgenol; 2017 Jun; 208(6):1392-1399. PubMed ID: 28792802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast magnetic resonance imaging as a problem-solving modality in mammographic BI-RADS 3 lesions.
    Dorrius MD; Pijnappel RM; Jansen-van der Weide MC; Oudkerk M
    Cancer Imaging; 2010 Oct; 10 Spec no A(1A):S54-8. PubMed ID: 20880790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast MRI in the evaluation of locally recurrent or new breast cancer in the postoperative patient: correlation of morphology and enhancement features with the BI-RADS category.
    Seely JM; Nguyen ET; Jaffey J
    Acta Radiol; 2007 Oct; 48(8):838-45. PubMed ID: 17851971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study.
    Baltzer PA; Benndorf M; Dietzel M; Gajda M; Runnebaum IB; Kaiser WA
    AJR Am J Roentgenol; 2010 Jun; 194(6):1658-63. PubMed ID: 20489110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and Cancer Yield of BI-RADS Category 3 Lesions Detected at High-Risk Screening Breast MRI.
    Edmonds CE; Lamb LR; Mercaldo SF; Sippo DA; Burk KS; Lehman CD
    AJR Am J Roentgenol; 2020 Feb; 214(2):240-248. PubMed ID: 31799867
    [No Abstract]   [Full Text] [Related]  

  • 18. Breast MRI as an adjunct to mammography: Does it really suffer from low specificity? A retrospective analysis stratified by mammographic BI-RADS classes.
    Benndorf M; Baltzer PA; Vag T; Gajda M; Runnebaum IB; Kaiser WA
    Acta Radiol; 2010 Sep; 51(7):715-21. PubMed ID: 20707656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of BI-RADS Descriptors in Contrast-Enhanced Dual-Energy Mammography: Comparison with MRI.
    Knogler T; Homolka P; Hoernig M; Leithner R; Langs G; Waitzbauer M; Pinker K; Leitner S; Helbich TH
    Breast Care (Basel); 2017 Sep; 12(4):212-216. PubMed ID: 29070983
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.